247 related articles for article (PubMed ID: 27650729)
21. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives.
Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Petzer JP; Firgang SI; Suponitsky KY
Bioorg Med Chem Lett; 2015 Mar; 25(6):1206-11. PubMed ID: 25701250
[TBL] [Abstract][Full Text] [Related]
23. Preventive effects of fructose and N-acetyl-L-cysteine against cytotoxicity induced by the psychoactive compounds N-methyl-5-(2-aminopropyl)benzofuran and 3,4-methylenedioxy-N-methamphetamine in isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Inomata A
J Appl Toxicol; 2018 Feb; 38(2):284-291. PubMed ID: 28949027
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
25. Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.
Heinrich T; Böttcher H; Schiemann K; Hölzemann G; Schwarz M; Bartoszyk GD; van Amsterdam C; Greiner HE; Seyfried CA
Bioorg Med Chem; 2004 Sep; 12(18):4843-52. PubMed ID: 15336263
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803
[TBL] [Abstract][Full Text] [Related]
27. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Biezonski DK; Meyer JS
J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
[TBL] [Abstract][Full Text] [Related]
28. The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.
Marusich JA; Antonazzo KR; Blough BE; Brandt SD; Kavanagh PV; Partilla JS; Baumann MH
Neuropharmacology; 2016 Feb; 101():68-75. PubMed ID: 26362361
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).
Young MB; Norrholm SD; Khoury LM; Jovanovic T; Rauch SAM; Reiff CM; Dunlop BW; Rothbaum BO; Howell LL
Psychopharmacology (Berl); 2017 Oct; 234(19):2883-2895. PubMed ID: 28741031
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives.
Simmler LD; Rickli A; Schramm Y; Hoener MC; Liechti ME
Biochem Pharmacol; 2014 Mar; 88(2):237-44. PubMed ID: 24486525
[TBL] [Abstract][Full Text] [Related]
32. Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine.
Johnson CB; Walther D; Baggott MJ; Baker LE; Baumann MH
J Pharmacol Exp Ther; 2024 Jan; ():. PubMed ID: 38272669
[TBL] [Abstract][Full Text] [Related]
33. Interaction of indole derivatives with monoamine oxidase A and B. Studies on the structure-inhibitory activity relationship.
Medvedev AE; Ivanov AS; Kamyshanskaya NS; Kirkel AZ; Moskvitina TA; Gorkin VZ; Li NY; Marshakov VYu
Biochem Mol Biol Int; 1995 May; 36(1):113-22. PubMed ID: 7663405
[TBL] [Abstract][Full Text] [Related]
34. A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.
Geldenhuys WJ; Funk MO; Van der Schyf CJ; Carroll RT
Bioorg Med Chem Lett; 2012 Feb; 22(3):1380-3. PubMed ID: 22225638
[TBL] [Abstract][Full Text] [Related]
35. Novel Diels-Alder Type Adducts from
Paudel P; Park SE; Seong SH; Jung HA; Choi JS
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835621
[TBL] [Abstract][Full Text] [Related]
36. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
Tzvetkov NT; Hinz S; Küppers P; Gastreich M; Müller CE
J Med Chem; 2014 Aug; 57(15):6679-703. PubMed ID: 24955776
[TBL] [Abstract][Full Text] [Related]
37. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
Ball KT; Rebec GV
Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
[TBL] [Abstract][Full Text] [Related]
39. Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase.
Booysen HP; Moraal C; Terre'Blanche G; Petzer A; Bergh JJ; Petzer JP
Bioorg Med Chem; 2011 Dec; 19(24):7507-18. PubMed ID: 22055712
[TBL] [Abstract][Full Text] [Related]
40. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K; Liljefors T; Hyttel J; Perregaard J
J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]